Monitoring Symptoms to Help Young Women Take Hormone Therapy for Stage I-III Breast Cancer, ASPEN Study

Major Program
Supportive Care and Symptom Management
NCI Community Oncology Research Program
Research Group
Community Oncology and Prevention Trials
Southwest Oncology Group
Recruiting ID
For more information, see NCT05568472
This phase III trial compares the effect of active symptom monitoring and patient education
to patient education alone in helping young women with stage I-III breast cancer stay on
their hormone therapy medicines. The patient education tool contains interactive weblinks
which provide patients with education material about breast cancer and side effects of
therapy. Symptom monitoring is a weblink via email or text message with questions asking
about symptoms. Hormone therapy for breast cancer can cause side effects, and may cause some
women to stop treatment early. Asking about symptoms more often may help women keep taking
hormone therapy medicines.
Best Practice, Biospecimen Collection, Endocrine Drug Therapy, Health Education, Questionnaire Administration, Symptom Specific Assessment Tool
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Hormone Receptor-Positive Breast Carcinoma
Norah L Henry

See list of participating sites